Dewey Steadman | Head, IR |
Martine Rothblatt | Chairman and CEO |
Michael Benkowitz | President and COO |
Leigh Peterson | VP, Product Development |
James Edgemond | CFO and Treasurer |
Joseph Thome | Cowen and Company |
Liana Moussatos | Wedbush |
Eun Yang | Jefferies |
Jessica Fye | JPMorgan |
Martin Auster | Credit Suisse |
Hartaj Singh | Oppenheimer |
Terence Flynn | Goldman Sachs |
Good morning, and welcome to the United Therapeutics Corporation, Fourth Quarter 2020 Earnings Call. My name is Kenzie, and I will be your conference operator today. [Operator Instructions] I will now turn the conference call over to Mr. Dewey Steadman, Head of Investor Relations at United Therapeutics.
Good morning.